Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr Ryuji Sakakibara
Neurology Clinic Tsudanuma

ICS 2022

Podium Short Oral Session 17 Nocturia 247 Parkinson’s disease and nocturnal polyuria

Open Discussion Session 22 Open Discussion ePosters 344 Lower urinary tract symptoms in myasthenia gravis

ICS 2021

Open Discussion Session 19 On Demand Geriatrics / Gerontology 251 Triple-disease etiology is common for LUTS in octogenarians: A neuro-urological approach

ICS 2020

Open Discussion Session 25 ePoster 6 402 Probable ‘premotor’ multiple system atrophy-cerebellar form

ICS 2019

Open Discussion Session 7 E-Poster 1 92 Lewy body constipation

ICS 2018

Podium Short Oral Session 4 Neurogenic Bladder 33 “Bladder-first” form of multiple system atrophy: a message from uro-neurologists

ICS 2017

Open Discussion Session 9 Open Discussion ePosters 1 124 Relationship between bladder, periarterial and somatic neuropathy in diabetes

Open Discussion Session 9 Open Discussion ePosters 1 126 Parkinson’s disease and prostate hyperplasia: which is more contributing to overactive bladder?

Open Discussion Session 9 Open Discussion ePosters 1 127 Bladder first-sensation-volume increase is primary in diabetic neuropathy: a five-grade measure

Non Discussion Abstract Session 41 Non Discussion Abstracts 891 Gatrointestinal dysfunction in dementia with Lewy bodies: a comparison with Parkinson’s disease

ICS 2016

Podium Express Session 22 Rapid Communications in Conservative Management 401 Nizatidine ameliorates gastroparesis and slow transit constipation in Parkinson’s disease

Podium Express Session 22 Rapid Communications in Conservative Management 402 Levodopa does not worsen gastroparesis and slow transit constipation in Parkinson’s disease

ICS 2015

Podium Short Oral Session 28 Neurourology 429 Lower urinary tract dysfunction in progressive supranuclear palsy

Podium Short Oral Session 28 Neurourology 436 Transdermal dopamine agonist ameliorates gastric emptying in Parkinson’s disease

Podium Short Oral Session 34 Pharmacotherapy for Overactive Bladder 495 Fesoterodine modulates the brain function in OAB patients: a real-time measure of oxyhemoglobin concentration changes during urodynamics

ICS 2014

Podium Session 28 Neurourology 408 Meningitis-retention syndrome - a neuro-urological analysis

Plenary Podium Session 44 Neurology of Continence 673 Brain SPECT imaging for the bladder of normal pressure hydrocephalus (NPH) – results of two analyses -

ICS 2013

Non Discussion Poster Session 34 541 Cognitive safety and overall tolerability of imidafenacin in routine clinical use : Long-term, open-label, post-marketing surveillance study

Non Discussion Abstract Session 35 Read By Title 733 “Meningitis?retention syndrome” - a urodynamic study of 8 cases

ICS 2012

Podium Session 12 Neurourology: Clinical II 125 Tolterodine activates the frontal micturition area of OAB patients: a real-time measure of oxyhemoglobin concentration changes during urodynamics

Podium Poster Session 22 Gerontology 189 Inhibitory control task is decreased in vascular incontinence patients

Non Discussion Abstract Session 32 Read By Title 681 Influences of imidafenacin on cognitive function in patients with overactive bladder

ICS 2011

Podium Poster Session 4 Neurourology 37 Evaluation of imidafenacin on urinary sensation and brain function using real-time measurement of oxyhemoglobin concentration changes in frontal micturition area of OAB patients

Podium Poster Session 4 Neurourology 39 White matter lesions versus Alzheimer’s disease: which is more significant burden on OAB and incontinence in the elderly dementia?

Non Discussion Poster Session 29 479 Relationship between detrusor overactivity with frontal cognitive hypo-function ; a study in elderly dementia with OAB


Podium Session 13 Assessment and Conservative Treatment 118 Increase in bilateral mid-cingulate blood flow related to bladder recovery in idiopathic normal pressure hydrocephalus after shunt surgery

Non Discussion Poster Session 31 436 Levodopa’s effects on anorectal constipation in de novo Parkinson's disease patients: the QL-GAT study

Non Discussion Poster Session 31 818 Real-time five-grade bladder sensory measurement

ICS 2009

Podium Poster Session 30 Anatomy & Imaging 276 Real-time measurement of oxyhemoglobin concentration changes in the frontal micturition area: an fNIRS study

Non Discussion Poster Session 32 381 Influence of body position on defecation in humans

Non Discussion Poster Session 32 392 Bladder sensation and neurologic diseases

ICS 2008

Non Discussion Poster Session 19 272 Quantitative lower-gastrointestinal autonomic test (QL-GAT): bowel assessment before and after levodopa in denovo Parkinson's disease

Podium Poster Session 11 Ageing 94 Geriatric OAB: propiverine (a peripheral anticholinergic agent) can be added on to donepezil (a central cholinergic agent) without cognitive alteration

ICS 2007

Non Discussion Poster Session 17 214 Hypo- and hyper-active lumbosacral nerves cause urinary dysfunction in Guillain-Barré syndrome

Podium Session 2 The Brain and the Bladder:Room: Grote Zaal - Chairs: Tony Stone & Gert Holstege Urinary dysfunction and right frontal hypoperfusion in idiopathic normal pressure hydrocephalus; an [123I]-IMP SPECT study

View ICS Committee Member Details

Ryuji Sakakibara

ICS Committee Member

Qualifications:PhD Professor
You must be logged in to view this contact
to ICS

Dr. Ryuji Sakakibara was born and raised in Japan. He received his medical degree from the Asahikawa Medical College in 1984. Because of interest in clinical neurology, he moved forward to Chiba University (Professor Keizo Hirayama) where he subsequently worked as an assistant Professor, and a Lecturer in the Department of Neurology. He completed his Ph.D. at the Department of Neurology, Chiba University, in 1992 (Professor Takamichi hattori). From 1997 to 1998 he was a research fellow in the National Hospital for Neurology and Neurosurgery / Institute of Neurology, Queen Square, London, supervised by Professor Clare J. Fowler in the Department of Uro-Neurology. In 2007 March, he started a new Department of Neurology in Toho University, Sakura Medical Center, Sakura, Japan as an Associate Professor, and from 2016, Professor of Neurology. In 2023, he now started work at 🧠Neurology Clinic Tsudanuma & 🧠Dowakai Chiba Hospital. He is a member of many international societies including the American Academy of Neurology, the Association of British Neurologists, the Movement Disorders Society, the International Society for Autonomic Neuroscience, the European Federation of Autonomic Societies, the American Autonomic Society, the International Continence Society, and the International Consultation on Incontinence. He also serves as an adhoc reviewer of several journals including Neuroscience Letters, Journal of Neurology, Neurosurgery & Psychiatry, Journal of Neurology, European Journal of Neurology, Movement Disorders, Muscle and Nerve, Urology, Journal of Urology, Clinical Physiology, and American Journal of Physiological Medicine. During his career, Dr. Sakakibara has authored more than 250 articles in peer-reviewed international journals (PubMed).
SYNOPSIS OF AREA OF INTEREST: Dr. Sakakibara's research interests include neuro-urology, neuro-gastroenterology, autonomic physiology, drug trials and clinical neurology including Parkinson’s disease and multiple system atrophy.

Dr Ryuji Sakakibara declared on the Monday 12th February 2024 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).